Filing Details
- Accession Number:
- 0000950170-23-070416
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-14 16:30:08
- Reporting Period:
- 2023-12-12
- Accepted Time:
- 2023-12-14 16:30:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1157601 | Madrigal Pharmaceuticals Inc. | MDGL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1876996 | E. Robert Waltermire | C/O Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428 | Senior Vp, Chief Pharma Dev. | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-12 | 1,300 | $87.92 | 6,967 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-12-12 | 500 | $216.00 | 6,467 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-12-12 | 800 | $219.00 | 5,667 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-12-13 | 2,500 | $87.92 | 8,167 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-12-13 | 1,500 | $225.00 | 6,667 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-12-13 | 1,000 | $226.00 | 5,667 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-12-12 | 1,300 | $0.00 | 1,300 | $87.92 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-12-13 | 2,500 | $0.00 | 2,500 | $87.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 23,700 | 2031-08-02 | No | 4 | M | Direct | |
| 21,200 | 2031-08-02 | No | 4 | M | Direct |
Footnotes
- All shares issued pursuant to the exercise of the options reported herein represent 3,800 shares underlying an overall option award of 35,000 shares. All exercised options had vested. As to the overall option for 35,000 shares, 25% of the shares underlying the option vested on August 2, 2022 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
Billionaire Hedge Funds
